What can your patients gain with Serostim®?

Serostim® is indicated for the treatment of HIV patients with wasting or cachexia to increase lean body mass and body weight and improve physical endurance. Concomitant antiretroviral therapy is necessary.1

Recognize HIV-associated wasting

What can your patients gain with Serostim®?

Serostim® is indicated for the treatment of HIV patients with wasting or cachexia to increase lean body mass and body weight and improve physical endurance. Concomitant antiretroviral therapy is necessary.1

Recognize HIV-associated wasting

Serostim® improves 3 key symptoms of HIV-associated wasting

Serostim® is the only FDA-approved treatment proven to increase weight and lean body mass (LBM), as well as improve physical endurance. For over 20 years, Serostim® has been prescribed to treat patients with HIV-associated wasting. Concomitant antiretroviral therapy is necessary.1,2

In clinical trials, Serostim® significantly increased physical endurance, LBM, and weight2

One study was a 12-week, double-blind, placebo-controlled study in which 757 patients with HIV-associated wasting or cachexia were given Serostim® 0.1 mg/kg taken every day, Serostim® 0.1 mg/kg taken every other day, or a placebo.

Read more

Important resources for you

Download these documents to get your patients started on Serostim®
Serostim® Dosing Card
Statement of Medical Necessity

Show References

Hide References

  1. Serostim® (somatropin) [prescribing Information]. Rockland, MA: EMD Serono, Inc; 2018.
  2. Moyle GJ, Daar ES, Gertner JM, et al. Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2004;35(4):367-375.